• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.64% Nasdaq Down0.55%

    More On LLTP



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates



    Lightlake Therapeutics Inc. (LLTP)

    -Other OTC
    6.29 Up 0.04(0.64%) 3:50PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Lightlake Therapeutics Inc.
    96-98 Baker Street
    First Floor
    London, W1U 6TJ
    United Kingdom - Map
    Phone: 44 20 3617 8739
    Fax: 44 20 7034 1943
    Website: http://www.lightlaketherapeutics.com

    Index Membership:N/A
    Full Time Employees:3

    Business Summary 

    Lightlake Therapeutics Inc., an early stage biopharmaceutical company, develops treatments for common addictions and related disorders. It focuses on developing a treatment to reverse opioid overdoses; a treatment for overweight and obese patients with binge eating disorder; and a treatment for patients with bulimia nervosa. The company was formerly known as Madrona Ventures, Inc. and changed its name to Lightlake Therapeutics Inc. in September 2009. Lightlake Therapeutics Inc. was founded in 2005 and is based in London, the United Kingdom.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Lightlake Therapeutics Inc.

    Key Executives 
    Dr. Michael J. Sinclair M.D., 72
    Exec. Chairman
    Dr. Roger Crystal , 39
    Chief Exec. Officer, Pres and Director
    Mr. Arvind Agrawal ,
    Exec. VP of Medical Affairs
    Prof. Martin R. Wilkins ,
    Medical Advisor
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders